Treatment of Helicobacter pylori and prevention of gastric cancer.

Abstract

Gastric cancer is the second commonest fatal malignancy in the world with a high incidence in China. Helicobacter pylori infection is an important factor in the pathogenesis of gastric cancer. Epidemiological studies have shown a strong causal relationship between H. pylori infection and gastric cancer. Animal studies also show that eradication of H. pylori infection, especially at the early stage, is effective in preventing H. pylori-related gastric carcinogenesis. H. pylori eradication leads to regression and prevents the progression of gastric precancerous lesions, but only in a minority of cases. H. pylori eradication appears to be the most promising approach in gastric cancer prevention. The current available data in human studies showed that H. pylori eradication can reduce the risk of developing gastric cancer and this strategy is more useful in patients without atrophic gastritis or intestinal metaplasia. A longer follow-up and additional studies are needed for better understanding this issue.

DOI: 10.1111/j.1443-9573.2007.00315.x
02040602008200920102011201220132014201520162017
Citations per Year

78 Citations

Semantic Scholar estimates that this publication has 78 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Cheung2008TreatmentOH, title={Treatment of Helicobacter pylori and prevention of gastric cancer.}, author={Ting Kin Cheung and Benjamin Chun-yu Wong}, journal={Journal of digestive diseases}, year={2008}, volume={9 1}, pages={8-13} }